EP Patent

EP1836452A2 — Apparatus and method for measuring the acceleration imparted on metered dose delivery containers

Assigned to GlaxoSmithKline LLC · Expires 2007-09-26 · 19y expired

What this patent protects

An apparatus (100)comprises a main body member (110), and a transducer (120) in communication with the main body member, transducer adapted to receive an acceleration force imparted to the main body member. A method for assessing acceleration forces imparted to an apparatus compr…

USPTO Abstract

An apparatus (100)comprises a main body member (110), and a transducer (120) in communication with the main body member, transducer adapted to receive an acceleration force imparted to the main body member. A method for assessing acceleration forces imparted to an apparatus comprises a main body member (110) and transducer (120) in communication with the main body member the transducer adapted to receive the external acceleration force imparted to the main body member, wherein the transducer converts the acceleration forces to electrical signals and the acceleration

Drugs covered by this patent

Patent Metadata

Patent number
EP1836452A2
Jurisdiction
EP
Classification
—
Expires
2007-09-26
Drug substance claim
No
Drug product claim
No
Assignee
GlaxoSmithKline LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.